Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
6766 | 1370 | 31.2 | 87% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
597 | 13382 | HEPATOCELLULAR CARCINOMA//HEPATOBLASTOMA//GLYPICAN 3 |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | MILAN CRITERIA | Author keyword | 118 | 73% | 7% | 91 |
2 | UCSF CRITERIA | Author keyword | 21 | 90% | 1% | 9 |
3 | SALVAGE LIVER TRANSPLANTATION | Author keyword | 12 | 86% | 0% | 6 |
4 | ALPHA FETOPROTEIN MRNA | Author keyword | 11 | 78% | 1% | 7 |
5 | SALVAGE TRANSPLANTATION | Author keyword | 8 | 70% | 1% | 7 |
6 | UNITA CHIRURG EPATOBILIARE TR IANTO EPAT | Address | 8 | 60% | 1% | 9 |
7 | AFP MRNA | Author keyword | 8 | 62% | 1% | 8 |
8 | LOCO REGIONAL THERAPY | Author keyword | 6 | 58% | 1% | 7 |
9 | EXPANDED CRITERIA | Author keyword | 6 | 45% | 1% | 10 |
10 | UP TO SEVEN CRITERIA | Author keyword | 6 | 100% | 0% | 4 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MILAN CRITERIA | 118 | 73% | 7% | 91 | Search MILAN+CRITERIA | Search MILAN+CRITERIA |
2 | UCSF CRITERIA | 21 | 90% | 1% | 9 | Search UCSF+CRITERIA | Search UCSF+CRITERIA |
3 | SALVAGE LIVER TRANSPLANTATION | 12 | 86% | 0% | 6 | Search SALVAGE+LIVER+TRANSPLANTATION | Search SALVAGE+LIVER+TRANSPLANTATION |
4 | ALPHA FETOPROTEIN MRNA | 11 | 78% | 1% | 7 | Search ALPHA+FETOPROTEIN+MRNA | Search ALPHA+FETOPROTEIN+MRNA |
5 | SALVAGE TRANSPLANTATION | 8 | 70% | 1% | 7 | Search SALVAGE+TRANSPLANTATION | Search SALVAGE+TRANSPLANTATION |
6 | AFP MRNA | 8 | 62% | 1% | 8 | Search AFP+MRNA | Search AFP+MRNA |
7 | LOCO REGIONAL THERAPY | 6 | 58% | 1% | 7 | Search LOCO+REGIONAL+THERAPY | Search LOCO+REGIONAL+THERAPY |
8 | EXPANDED CRITERIA | 6 | 45% | 1% | 10 | Search EXPANDED+CRITERIA | Search EXPANDED+CRITERIA |
9 | UP TO SEVEN CRITERIA | 6 | 100% | 0% | 4 | Search UP+TO+SEVEN+CRITERIA | Search UP+TO+SEVEN+CRITERIA |
10 | DOWNSTAGE | 4 | 67% | 0% | 4 | Search DOWNSTAGE | Search DOWNSTAGE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MILAN CRITERIA | 147 | 60% | 12% | 160 |
2 | EXPANDED CRITERIA | 68 | 70% | 4% | 57 |
3 | SALVAGE TRANSPLANTATION | 57 | 69% | 4% | 49 |
4 | WAITING LIST | 39 | 25% | 10% | 133 |
5 | REASONABLE STRATEGY | 33 | 77% | 2% | 23 |
6 | TO TREAT ANALYSIS | 26 | 35% | 4% | 60 |
7 | CIRCULATING HEPATOCYTES | 23 | 86% | 1% | 12 |
8 | ORGAN ALLOCATION POLICY | 21 | 75% | 1% | 15 |
9 | TRANSARTERIAL LIPIODOL CHEMOEMBOLIZATION | 17 | 40% | 2% | 33 |
10 | ALLOCATION POLICY | 16 | 51% | 2% | 22 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report | 2012 | 151 | 82 | 67% |
Systematic review of outcome of downstaging hepatocellular cancer before liver transplantation in patients outside the Milan criteria | 2011 | 27 | 40 | 85% |
Hepatocellular cancer: how to expand safely inclusion criteria for liver transplantation | 2014 | 5 | 36 | 72% |
Liver transplantation for hepatocellular carcinoma: Beyond the Milan criteria | 2008 | 73 | 27 | 96% |
Recurrence of hepatocellular carcinoma following liver transplantation - A review of preoperative and postoperative prognostic indicators | 2008 | 87 | 62 | 81% |
Toward a Better Liver Graft Allocation That Accounts for Candidates With and Without Hepatocellular Carcinoma | 2014 | 4 | 34 | 71% |
Summary of Candidate Selection and Expanded Criteria for Liver Transplantation for Hepatocellular Carcinoma: A Review and Consensus Statement | 2011 | 18 | 36 | 92% |
Recurrent hepatocellular carcinoma after liver transplantation - an emerging clinical challenge | 2013 | 16 | 81 | 56% |
Systematic review of outcomes of liver resection for early hepatocellular carcinoma within the Milan criteria | 2012 | 34 | 50 | 54% |
Adverse events affect sorafenib efficacy in patients with recurrent hepatocellular carcinoma after liver transplantation: experience at a single center and review of the literature | 2013 | 16 | 36 | 53% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | UNITA CHIRURG EPATOBILIARE TR IANTO EPAT | 8 | 60% | 0.7% | 9 |
2 | SECT HEPATOBILIARY PANCREAT TRANSPLANT SURG | 5 | 54% | 0.5% | 7 |
3 | DIPARTIMENTO CHIRURG GEN TR IANTI | 4 | 75% | 0.2% | 3 |
4 | UNITA CHIRURG ONCOL | 4 | 46% | 0.4% | 6 |
5 | ABDOMINAL ORGAN TRANSPLANT UNIT | 2 | 67% | 0.1% | 2 |
6 | FDN PTV | 2 | 50% | 0.2% | 3 |
7 | HBP SURG TRANSPLANTAT | 2 | 40% | 0.3% | 4 |
8 | UNITA BIOSTAT EPIDEMIOL | 2 | 28% | 0.4% | 5 |
9 | STARZL UNIT ABDOMINAL TRANSPLANTAT | 2 | 33% | 0.3% | 4 |
10 | ORGAN TRANSPLANTAT REGENERAT MED | 2 | 22% | 0.4% | 6 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000270480 | HEPATOCELLULAR CARCINOMA//TRANSARTERIAL CHEMOEMBOLIZATION//MIRIPLATIN |
2 | 0.0000112620 | MELD//MODEL FOR END STAGE LIVER DISEASE//DONOR RISK INDEX |
3 | 0.0000079947 | DES GAMMA CARBOXY PROTHROMBIN//GOLGI PROTEIN 73//GP73 |
4 | 0.0000078009 | FIBROLAMELLAR HEPATOCELLULAR CARCINOMA//FIBROLAMELLAR CARCINOMA//COMBINED HEPATOCELLULAR AND CHOLANGIOCARCINOMA |
5 | 0.0000072284 | RADIO FREQUENCY ABLATION//MICROWAVE ABLATION//RADIOFREQUENCY RF ABLATION |
6 | 0.0000060888 | RUPTURED HEPATOCELLULAR CARCINOMA//EXTRAHEPATIC METASTASIS//SKULL METASTASIS |
7 | 0.0000057767 | LIVING DONOR LIVER TRANSPLANTATION//SMALL FOR SIZE SYNDROME//MIDDLE HEPATIC VEIN |
8 | 0.0000057702 | GD EOB DTPA//GADOXETIC ACID//GADOXETATE DISODIUM |
9 | 0.0000056153 | HEPATITIS B IMMUNOGLOBULIN//HBIG//HEPATITIS B RECURRENCE |
10 | 0.0000051854 | HEPATITIS C RECURRENCE//RECURRENT HEPATITIS C//HCV RECURRENCE |